Bone Disease and Serum Fibroblast Growth Factor-23 Levels in Renal Transplant Recipients


COSKUN Y., PAYDAŞ S. , BALAL M. , SOYUPAK S. , KARA E.

TRANSPLANTATION PROCEEDINGS, cilt.48, ss.2040-2045, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Background. Posttransplantation bone disease develops commonly and results in important complications. In this study, we aimed to investigate the relationship between bone diseases and serum fibroblast growth factor-23 (FGF-23) in renal transplant recipients.